Ki Summary

Reaction Details

Report a problem with these data

Target

Gastric inhibitory polypeptide

Ligand

BDBM50244299

Substrate/Competitor

n/a

Meas. Tech.

ChEMBL_491828 (CHEMBL945218)

IC50

6000±n/a nM

Citation

Kim, RM; Chang, J; Lins, AR; Brady, E; Candelore, MR; Dallas-Yang, Q; Ding, V; Dragovic, J; Iliff, S; Jiang, G; Mock, S; Qureshi, S; Saperstein, R; Szalkowski, D; Tamvakopoulos, C; Tota, L; Wright, M; Yang, X; Tata, JR; Chapman, K; Zhang, BB; Parmee, ER Discovery of potent, orally active benzimidazole glucagon receptor antagonists. Bioorg Med Chem Lett18:3701-5 (2008) [PubMed] Article

More Info.:

Get all data from this article, Assay Method

Gastric inhibitory polypeptide

Name:

Gastric inhibitory polypeptide

Synonyms:

GIP | GIP_HUMAN

Type:

PROTEIN

Mol. Mass.:

17110.38

Organism:

Homo sapiens (Human)

Description:

ChEMBL_491828

Residue:

153

Sequence:

MVATKTFALLLLSLFLAVGLGEKKEGHFSALPSLPVGSHAKVSSPQPRGPRYAEGTFISD
YSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQREARALELASQANRKEEEAVEPQSSPA
KNPSDEDLLRDLLIQELLACLLDQTNLCRLRSR

BDBM50244299

n/a

Name

BDBM50244299

Synonyms:

CHEMBL480501 | trans-4-(((4-tert-butylcyclohexyl)(1-methyl-5-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)amino)methyl)-N-(1H-tetrazol-5-yl)benzamide

Type

Small organic molecule

Emp. Form.

C28H33F3N8O

Mol. Mass.

554.6098

SMILES

Cn1c(nc2cc(ccc12)C(F)(F)F)N(Cc1ccc(cc1)C(=O)Nc1nnn[nH]1)[C@H]1CC[C@@H](CC1)C(C)(C)C |r,wU:30.33,wD:33.40,(-5.67,-48.6,;-4.89,-47.26,;-3.47,-46.67,;-3.59,-45.14,;-5.09,-44.78,;-5.82,-43.43,;-7.36,-43.39,;-8.16,-44.71,;-7.42,-46.06,;-5.89,-46.09,;-8.1,-42.04,;-8.88,-40.7,;-6.76,-41.28,;-9.43,-42.81,;-2.14,-47.45,;-2.14,-48.99,;-.81,-49.77,;.52,-49,;1.84,-49.78,;1.84,-51.32,;.49,-52.08,;-.83,-51.3,;3.17,-52.1,;3.16,-53.64,;4.5,-51.33,;5.83,-52.11,;6.35,-53.56,;7.89,-53.52,;8.33,-52.05,;7.06,-51.17,;-.81,-46.69,;-.8,-45.15,;.54,-44.39,;1.87,-45.17,;1.85,-46.71,;.52,-47.47,;3.21,-44.41,;4.53,-43.63,;3.98,-45.75,;2.45,-43.08,)|

Structure